US Edition
Published • loading... • Updated
DAS Pharma Gets SEC Nod to Delay 2025 Audited Accounts
Summary by News Ghana
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
DAS Pharma Gets SEC Nod to Delay 2025 Audited Accounts
NewsGhana, Latest Updates and Breaking News of Ghana, Roger A. Agana, https://www.newsghana.com.gh/das-pharma-gets-sec-nod-to-delay-2025-audited-accounts/Dannex Ayrton Starwin Plc has secured regulatory approval to delay publication of its full-year 2025 audited financial statements, with the Securities and Exchange Commission (SEC) granting the listed pharmaceutical manufacturer an extension to submit the accounts by April 30, 2026. The disclos…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
